Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation
Current Oncology · 2025
DOI: 10.3390/curroncol33010010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Sebastian Skoczylas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Medical University of Lodz, 92-213 Lodz, Poland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Germ-Line Mutation, DNA Copy Number Variations, Breast Neoplasms. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Pathogenic and likely pathogenic variants in the BRCA1 and BRCA2 genes are associated with a significantly increased risk of breast and/or ovarian cancer. We investigated genetic variants in a cohort of 450 unaffected individuals with a family history of breast and/or ovarian cancer, involving at least one first-degree relative.
Methods
Next-generation sequencing (NGS) was used to analyze the coding regions of these two genes, with copy number variation (CNV) analysis.
Results
A total of 16 unique to our cohort variants classified as pathogenic or likely pathogenic were identified in 22 patients, including one novel loss-of-function variant in BRCA1 gene. Furthermore, we identified a deletion of exon 21 in the BRCA1 gene in two patients.
Conclusions
These results emphasize the difficulties involved in molecular diagnostics and indicate the need for further research into new predictive models for patients with hereditary breast and ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Genetics, Medical University of Lodz, 92-213 Lodz, Poland.
- Student Society for Genetic Counselling and Clinical Genetics at the Department of Clinical Genetics, Medical University of Lodz, 92-213 Lodz, Poland.
ORCID-Profile: Sebastian Skoczylas, Tomasz Płoszaj, Izabela Dróżdż, Hanna Moczulska, Katarzyna Piekarska, Olga Wojtyczka, Agnieszka Zmysłowska
Zitieren
APA
Skoczylas, S., Płoszaj, T., Dróżdż, I., Moczulska, H., Serafin, M., Piekarska, K., Wojtyczka, O., Żeżawska, K., & Zmysłowska, A. (2025). Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation. Current Oncology. https://doi.org/10.3390/curroncol33010010
Vancouver
Skoczylas S, Płoszaj T, Dróżdż I, Moczulska H, Serafin M, Piekarska K, et al. Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation. Current Oncology. 2025. doi:10.3390/curroncol33010010
BibTeX
@article{Skoczylas2025,
author = {Skoczylas, Sebastian and Płoszaj, Tomasz and Dróżdż, Izabela and Moczulska, Hanna and Serafin, Marcin and Piekarska, Katarzyna and Wojtyczka, Olga and Żeżawska, Karolina and Zmysłowska, Agnieszka},
title = {Germline BRCA1/2 Variants in Polish Patients with Family History of Breast and Ovarian Cancer: Prevalence, CNV Detection, and Identification of a Novel Loss-of-Function Mutation},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol33010010}
}
EUVIMED